Epidemiology of Amyotrophic Lateral Sclerosis
Journal Title: Turkish Journal of Neurology - Year 2020, Vol 26, Issue 3
Abstract
There has been an increase in studies on amyotrophic lateral sclerosis (ALS) in the last thirty years. These studies show an ALS incidence rate that varies between 0.6 and 3.8 per 100,000 person-years. The incidence rate is significantly lower in Asia than in Europe and North America. ALS prevalence rates vary between 4.1 and 8.4 per 100,000. It is more common in men, and the male-to-female ratio is between 1 and 2. The mean age of ALS onset is between 51 and 66 years. Patients with familial ALS tend to have an earlier age of onset compared with patients with sporadic ALS. Some 58-82% of the cases have a spinal onset. The studies show age, male sex, and family history as risk factors. Other than these, lifestyle and exposure to environmental factors may have an effect. The period from the first symptoms to either invasive ventilatory support or death is between 24 and 50 months. ALS foci with high prevalence have been recorded in Guam, The Kii Peninsula, and New Guinea. Underdeveloped or developing countries show a speedy aging tendency, which points to an increased burden due to ALS in their future. Further epidemiologic studies with higher case numbers in different regions are needed to be able to enlighten causative associations of the disease.
Authors and Affiliations
Mehmet Rıfkı Aktekin, Hilmi Uysal
Keywords
Related Articles
- EP ID EP689418
- DOI 10.4274/tnd.2020.45549
- Views 183
- Downloads 0
Objective and Subjective Assessment of Physical Activity in Adults with Muscle Diseases
Objective: The aim of this study was to investigate the physical activity of adults with muscle diseases relative to healthy controls. Materials and Methods: Individuals participated in this cross-sectional study by com...
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Objective: Intravenous methylprednisolone (IVMP) is the most commonly used emergency treatment for multiple sclerosis (MS) attacks and the risk of adverse effects is high due to frequent use. The aim of our study was to...
Effects of Body Temperature Lowering on Visual Evoked Potentials in Patients with Multiple Sclerosis
Objective: Aggravation of neurologic symptoms in patients with multiple sclerosis (MS) due to heating is well known. This phenomenon, known as Uhthoff phenomenon (UP), is explained by transient conduction block in demyel...
The Use of Clobazam as Add-on Treatment in Resistant Epilepsy: Our Retrospective Clinical Data
Objective: Patients with drug-resistant focal or generalized epilepsy are important in terms of treatment and polytherapy necessity, adverse effect profiles of drugs, and seizure control difficulties. Clobazam (CLB), whi...
An Investigation of the Relationship Between the Carotid Intima-media Thickness and Trunk Control in the Acute Phase of Ischemic Cerebrovascular Disease
Objective: To investigate the relationship between the carotid intima-media thickness (tCIM) and trunk control in individuals in individuals who have the acute phase of ischemic cerebrovascular disease. Materials and Me...